- Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
-
Liang LY, Wong VWS, Wong GLH, Yip TCF
- KMID: 2538207
- Clin Mol Hepatol.
- 2023 Jan;29(1):113-117.
- doi: 10.3350/cmh.2022.0333
-
- CITED
-
- Close
- SHARE
-
- Close
- Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
-
Liang LY, Lee HW, Wong VWS, Yip TCF, Tse YK, Hui VWK, Lui GCY, Chan HLY, Wong GLH
- KMID: 2517633
- Clin Mol Hepatol.
- 2021 Jul;27(3):499-509.
- doi: 10.3350/cmh.2020.0333
Background/Aims: Serum fibrosis scores comprised of common laboratory tests have high utility to assess severity of liver fibrosis. We aimed to derive and validate a hepatocellular carcinoma (HCC) risk score... -
- CITED
-
- Close
- SHARE
-
- Close
- Unmet need in chronic hepatitis B management
-
Liang LY, Wong GL
- KMID: 2451920
- Clin Mol Hepatol.
- 2019 Jun;25(2):172-180.
- doi: 10.3350/cmh.2018.0106
Despite all these exciting developments, there remain some unmet needs in the management for patients with chronic hepatitis B (CHB). As majority of CHB patients are going to use oral... -
- CITED
-
- Close
- SHARE
-
- Close
